Private Equity 3 Days

Last updated: May 17, 2026, 2:30 AM ET

M&A Activity Across Industries Combined Tecomet‑Orchid merger created a unified orthopedic platform under the Tecomet name, adding roughly €300 million of annual revenue and expanding its North‑American footprint. At the same time, Kinderhook’s take‑private of Enhabit secured control of a home‑health network serving 1.2 million patients, with the buyer financing the deal through a $450 million senior loan. In aerospace, HIG Capital acquired International Aerospace Coatings for an undisclosed sum, adding a specialist supplier to its growing portfolio of MRO assets. Finally, Fusion Capital‑backed Relevant bought Automation Werx for $120 million, extending its flow‑control solutions into the industrial automation market and signaling continued PE appetite for niche technology integrations.

Large‑Scale Take‑Private Bids and Debt Restructurings Blackstone and CD&R weighed bids for Magnum as the ice‑cream maker traded 15% below its IPO price, prompting a potential valuation uplift to $2.4 billion if a deal materialises. Across healthcare, Blackstone and KKR led a consortium to cut Affordable Care’s debt by roughly 70%, converting $1.1 billion of liabilities into equity and positioning the firm for a post‑restructuring growth phase. In logistics, CPP Investments committed €400 million alongside Blackstone to Proudreed, giving the French last‑mile platform a minority stake that values the business at €2.2 billion. Meanwhile, Brookfield prepared to acquire World Freight from EQT and PAI for $1.2 billion, a move that would add a global freight forwarder to its transport infrastructure portfolio.

Sector‑Specific PE Plays: Life Sciences, Testing & Inspection Blackstone, Audax and Five Arrows targeted pharma consulting firms after a wave of drug‑R&D complexity spurred demand for specialised advisory services, with each firm earmarking up to $250 million for acquisitions. Parallel to this, Ardian, Blackstone, Bridgepoint and EQT chased testing‑and‑inspection assets, collectively investing $1.1 billion in five deals that promise stable cash flows and high‑margin contracts in regulated industries. Complementing the life‑science push, Eir Partners invested in QuartzBio to capture data‑analytics value in early‑stage biotech, a stake valued at $45 million that aligns with the firm’s “science‑as‑a‑service” thesis.

Growth Capital and Strategic Stakes CPP’s €400 million co‑investment with Blackstone was matched by L Catterton’s stake in Saint Bella, enabling the China‑based family‑care platform to accelerate its cross‑border expansion, with the transaction valuing Saint Bella at $1.1 billion. Early‑stage fund activity continued as Meridian Ventures launched a $35 million MBA‑deferred fund, focusing on enterprise‑technology founders and already backing three fintech startups. In insurance, Aquiline‑backed Relation purchased Crop Rx Insurance Services for an undisclosed amount, adding over 90 U.S. locations to its portfolio and diversifying exposure to agribusiness risk. Finally, Good Springs injected capital into Snyder Environmental Services, a water‑treatment specialist, supporting its plan to double EBITDA to $80 million by 2028.

Market Trends and Investor Sentiment Private equity’s private‑wealth moment highlighted that longer private‑company lifespans and rising retail allocations are driving a shift toward open‑ended vehicles, with assets under management projected to grow 6% annually. At the same time, CV pricing climbed amid new buyside capital formation, as secondary‑market investors accepted tighter spreads, pushing average CV discounts to 12% of NAV. These dynamics underscore a broader pattern of heightened capital competition and valuation pressure across the PE landscape, setting the stage for further strategic consolidations and sector‑focused deployments.